Cancer Clinical Trials | Maryland | Adventist HealthCare - Adventist HealthCare

Clinical Trials

Browse cancer clinical trials at Adventist HealthCare.

What’s a Clinical Trial?

A clinical trial is a research study that tests a new medical device, medication or other therapy before it’s widely available. The study is done to see if the treatment works safely. The results of the study help researchers learn better ways to prevent, detect or treat cancer.

Should I Participate in a Clinical Trial?

When you take part in a clinical trial, your health may improve from the treatment. But it may not, and you may have side effects. Talk to your doctor about the potential risks and benefits.

Expert Researchers

At Adventist HealthCare, your clinical trial will be led by a team of specialists made up of doctors, clinical research nurses, research associates and assistants who do more than 65 cancer studies each year.

Search Cancer Clinical Trials

Showing 1-8 of 8

Sorted By:

  • ERA 223

    Study to determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer.

  • IMbassador250

    Study evaluates the safety and efficacy of atezolizumab in combination with enzalutamide compared with enzalutamide alone in participants with mCRPC.

  • KEYNOTE-046

    Study of ADXS31-142 monotherapy and a combination of ADXS31-142 with Pembrolizumab (MK-3475) in patients with metastatic castration-resistant prostate cancer.

  • PRIMCAB

    Study to demonstrate the superiority in term of radiographic Progression-Free Survival (rPFS) of cabazitaxel in patients with metastatic Castration-Resistant Prostate Cancer.

  • REASSURE

    Study to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients.

  • SPARTAN

    The purpose of this study is to evaluate the efficacy and safety of ARN-509 in adult men with high-risk non-metastatic castration-resistant prostate cancer.

  • TITAN

    Study to determine if the addition of apalutamide to ADT provides superior efficacy in improving radiographic progression-free survival (rPFS).

  • VIABLE

    Study to determine whether DCVAC/PCa added onto Standard of Care Chemotherapy can improve survival times for patients with Metastatic Castration Resistant Prostate Cancer.

Page InfoPage
Showing trials 1-8 of 8

Talk to a Cancer Navigator

Request a free consultation today to learn about our services.

Request a Consult

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.